期刊文献+

P-gp和ABCG2在口腔鳞状细胞癌中的表达及临床病理意义 被引量:7

Expression of P-gp and ABCG2 in Oral Squamous Cell Carcinoma and Their Clinical Pathology Significance
下载PDF
导出
摘要 目的:研究肿瘤耐药相关基因P-糖蛋白(P-gp)和三磷酸腺苷结合转运蛋白G超家族成员(ABCG2)在口腔鳞状细胞癌组织中的表达及其与临床病理特征和预后的关系。方法:应用免疫组化Envision法检测口腔鳞状细胞癌组织76例及正常黏膜组织30例,观察肿瘤耐药相关基因P-gp和ABCG2的表达,同时回顾性研究了这些表达与口腔鳞状细胞癌发生、浸润及转移等临床病理学参数的关系。结果:口腔鳞状细胞癌组织中,P-gp和AB-CG2的表达阳性率分别为88.16%和80.26%。30例正常黏膜组织中,两者的表达率分别为60%和50%,差异有统计学意义(P<0.05)。口腔鳞状细胞癌组织中,P-gp在不同临床分期、不同浸润深度组之间阳性表达率的差异有统计学意义(P<0.05)。ABCG2在不同临床分期、有或无淋巴结转移组之间阳性表达率的差异有统计学意义(P<0.05)。P-gp与ABCG2的表达呈正相关r=0.228(P<0.05)。结论:P-gp和ABCG2在口腔鳞癌的发生发展中可能有协同作用。检测P-gp和ABCG2的表达对口腔鳞癌化疗方案的制定、判断预后有重要指导意义。 Objective: To investigate clinical pathology significance and expression of P-gp and ABCG2 in oral squamous cell carcinoma. Methods: Envision immunohistochemical method was used to detect the expressions of P -gp and ABCG2 in 76 cases of oral squamous cell carcinoma and in 30 cases of normal tissues, and to analyse the relationship between them and different clinical pathological factors. Results: The positive frequency of P-gp and ABCG2 in oral carcinoma tissues is 88. 16 % and 80.26%, and in normal tissues is 60% and 50%. The difference was statistically significant (P〈0.05). In different clinical stages and different depth of invasion of oral carcinoma the positive frequency of P-gp protein was statistically significant (P〈0.05). In different clinical stages and with or without lymph node metastasis of oral carcinoma the positive frequency of ABCG2 protein was statistically signifi- cant (P〈0.05). The expression of P-gp was positively correlated with ABCG2 (r=0. 228, P〈0.05). Conclusion: It is possibly that P-gp in coordination with ABCG2 in the pathogenesis of oral squamous cell carcinoma.
出处 《口腔医学研究》 CAS CSCD 2012年第1期32-35,共4页 Journal of Oral Science Research
基金 新疆医科大学科研创新基金(编号:xjc201012)
关键词 口腔鳞状细胞癌 P-糖蛋白 三磷酸腺苷结合转运蛋白G 超家族成员2 Oral squamous cell carcinoma P-gp ABCG2
  • 相关文献

参考文献13

  • 1程伟,童昕,马建民,温波,王芳芳,李岭.CXC类趋化因子受体4在口腔鳞状细胞癌中的表达及临床意义[J].国际口腔医学杂志,2010,37(5):502-503. 被引量:5
  • 2Kabanov AV , Batrakova EV, Alakhov VY. Pluronic block copolymers for overcoming drug resistance in cancer [J]. Adv Drug Deliv Rev, 2002, 54(5) : 759--779.
  • 3Tsuruo T, Naito M, Tomida A, et al. Molecular argeting therapy of cancer:drug resistance, apoptosis and survival sig- nal [J]. Cancer Sci, 2003, 94(1): 15--21.
  • 4Fojo AT , Ueda K, Slamon DJ , et al. Expression of a multi- drug resistance gene in human tumors and tissues [J]. Pro- ceedings of the National Academy of Sciences(USA) , 1987, 84(1) : 265--269.
  • 5周英琼,曾思恩,侯巧燕,陆明深,张美艳.P-gp、GST-Л、p53和CD44v6在肺癌中的表达[J].肿瘤防治研究,2005,32(11):699-701. 被引量:2
  • 6魏魁杰,潘红芽,韩伟,杨筱,叶冬霞,钟来平,张志愿.Lasp1 mRNA和蛋白在口腔鳞癌组织中表达上升及其临床意义[J].口腔医学研究,2011,27(1):37-39. 被引量:5
  • 7Camassei FD ,Arancia G,Cianf riglia M , et al. Nephroblas- toma : muhidrug--resistance P--glyeoprotein expression in tumor cells and intratumoral capillary endotholial cells [J]. Am J ClinPathol, 2002, 117(3) : 484--490.
  • 8Lacueva FJ , Calpena R, Medrano J, et al. Changes in P-- glycoprotein expression in gastril carcinoma with respect to distant gastric mucosa may be influenced by p53 [J]. Cancer, 2000, 89 (1): 21--28.
  • 9Jonker JW, Buitelaar M, Wagenaar E, et al. The breast cancer resistance protein protects against a major chlorophyll --derived dietary phototoxin and protoporphyria [J]. Proc Natl Acad Sci USA, 2002, 99(24): 15649--15654.
  • 10Zhang W, Shannon WD, Duncan J, et al. Expression of drug pathway proteins is independent of tumor type [J]. J Pathol, 2006, 209 (2) :213--219.

二级参考文献42

共引文献13

同被引文献69

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部